Translating antenatal magnesium sulphate neuroprotection for infants born <28 weeks' gestation into practice: A geographical cohort study.

Lex William DoyleAlicia J SpittleJoy E OlsenAmanda KwongRosemarie A BolandKatherine J LeePeter J AndersonJeanie L Y Cheongnull null

Published in: The Australian & New Zealand journal of obstetrics & gynaecology (2021)

Antenatal magnesium sulphate is being translated into clinical practice for infants born <28 weeks' gestation, but there is room for improvement. It is associated with lower rates of cerebral palsy in survivors.

Keyphrases

gestational age
preterm birth
cerebral palsy
clinical practice
pregnant women
low birth weight
primary care
healthcare
young adults
brain injury
quality improvement
cerebral ischemia